APA (7th ed.) Citation

Liu, H., Liu, H., Xia, Y., Chen, Y., Qi, H., Ji, H., . . . Lou, Y. (2025, October). RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant chemotherapy. Frontiers in Oncology.

Chicago Style (17th ed.) Citation

Liu, Hui, Hui Liu, Yufang Xia, Yunqing Chen, Huiyang Qi, Huixiang Ji, Shujun Ji, and Yanhui Lou. "RAD51 Protein Is a Predictor of Chemosensitivity and Survival Prognosis in Patients with Advanced High-grade Serous Ovarian Cancer Undergoing Neoadjuvant Chemotherapy." Frontiers in Oncology Oct. 2025.

MLA (9th ed.) Citation

Liu, Hui, et al. "RAD51 Protein Is a Predictor of Chemosensitivity and Survival Prognosis in Patients with Advanced High-grade Serous Ovarian Cancer Undergoing Neoadjuvant Chemotherapy." Frontiers in Oncology, Oct. 2025.